pyragrel
thromboxane A2-synthetase inhibitor for the treatment of cerebral infarction
Also Known As:
(E)-3-(3-methoxy-4-((3,5,6-trimethylpyrazine-2-yl) methoxy) phenyl) sodium acrylate
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Chen, Jun:
1 article
(07/2018)
|
| 2. | Fu, Chengxiao:
1 article
(07/2018)
|
| 3. | Huang, Jie:
1 article
(07/2018)
|
| 4. | Liu, Xiaolei:
1 article
(07/2018)
|
| 5. | Pei, Qi:
1 article
(07/2018)
|
| 6. | Tan, Hongyi:
1 article
(07/2018)
|
| 7. | Wang, Jing:
1 article
(07/2018)
|
| 8. | Xiang, Yuxia:
1 article
(07/2018)
|
| 9. | Yang, Guoping:
1 article
(07/2018)
|
| 10. | Yang, Shuang:
1 article
(07/2018)
|
Related Diseases
Related Drugs and Biologics